Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Daiichi Sankyo in the Drug Discovery & Development Pharma 50

Daiichi Sankyo

Rank: 30

2021 Rank: 24

Tokyo, Japan
www.daiichisankyo.com

2021 Revenues ($USD) : $9,512,855,062
2021 Revenues (foreign currencies) : JP¥1,044,892,000,000
2021 R&D spend : $2,313,583,394
2021 Number of Employees : 16033
Fiscal Year End : 3/31/2022
Leader : CEO Sunao Manabe

Tokyo-based Daiichi Sankyo specializes in developing oncology and cardiovascular drugs, as well as vaccines. It has 17 R&D locations in 10 countries throughout the world. Key drugs from Daiichi Sankyo include Enhertu, a HER2-directed antibody and topoisomerase inhibitor conjugate developed in collaboration with AstraZeneca and launched in the U.S. in 2020. Other notable drugs include Olmersaran (benicar), Turalio (pexidartinib), Vanflyta (quizartinib), Lixiana/Savaysa (edoxaban), Emgality (galcanezumab-gnlm), Canalia (teneligliptin, canagliflozin) and Sevaysa (edoxaban). Daiichi Sankyo also has generics and OTC businesses. —BB

Daiichi Sankyo

[Daiichi Sankyo facility in Basking Ridge, New Jersey. Image courtesy of Daiichi Sankyo.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE